SonoMotion Receives FDA De Novo Clearance for Stone Clear™ Device
SonoMotion, a pioneering medical device company committed to creating non-invasive solutions for kidney stone treatment, has recently celebrated a significant achievement. The company has received FDA de novo clearance for its innovative Stone Clear™ device, which facilitates the management of post-lithotripsy kidney stone fragments. This device is remarkable, as it represents the first and only technology employing ultrasound pulses to aid in the passage of kidney stone debris without the need for surgical intervention.
Understanding the Impact of Kidney Stones
Kidney stones are a prevalent health issue, impacting roughly one in ten individuals in the United States. They are not just uncomfortable, but also come with potential complications and costly healthcare expenditures that exceed $10 billion annually. For many patients dealing with the aftermath of lithotripsy, the absence of effective non-invasive treatment options for residual stones often leads to further complications, such as emergency room visits or repeat procedures.
The Groundbreaking Technology
Dr. James E. Lingeman, a Clinical Professor of Urology, emphasizes the urgent need for solutions: "Patients with post-lithotripsy residual fragments are more likely to face complications, yet currently, there are limited options available beyond mere observation." The Stone Clear device offers a non-invasive method for reducing this burden, enabling treatment directly in a clinical environment while patients remain awake and alert.
A Closer Look at the Stone Clear Device
The Stone Clear device operates on a groundbreaking platform that allows for the non-anesthetic treatment of kidney stones. It can be used in various healthcare environments, making it a versatile solution for patients. Interesting findings from related clinical studies have shown that using ultrasound propulsion for kidney stones can reduce the likelihood of relapse by an impressive 70%, compared to standard observation methods.
Future Developments and Innovations
SonoMotion is not stopping at the Stone Clear device. The company is also advancing a second treatment option, known as Break Wave™, designed to non-invasively fragment kidney stones located in the upper urinary tract. This innovative device, currently undergoing clinical trials, promises to broaden the scope of non-invasive treatment available to patients.
Vision and Goals of SonoMotion
Oren Levy, PhD, the Co-Founder and Chief Executive Officer of SonoMotion, remarks, "Achieving FDA clearance for Stone Clear is a pivotal milestone in our mission to revolutionize kidney stone treatment. Our technologies have the potential to serve as first-line treatments, empowering patients to avoid anesthesia and lengthy surgical waits." SonoMotion is dedicated to transforming the landscape of kidney stone care, and their advancements reflect a commitment to improving patient experiences and outcomes.
About SonoMotion
SonoMotion is a venture-capital-backed startup based in California, actively developing next-generation non-invasive solutions for kidney stone treatment. The Stone Clear device is now a crucial part of their offering, highlighting the evolving nature of medical technology aimed at improving patient care. It's important to note that the Break Wave device remains an investigational product and is not yet available for sale in the U.S. or other global markets.
Frequently Asked Questions
What is the Stone Clear™ device?
The Stone Clear device is an FDA-cleared technology that uses external ultrasound pulses to facilitate the non-invasive passage of kidney stone fragments.
How does Stone Clear differ from traditional treatments?
Unlike standard treatments that may require surgery or anesthesia, Stone Clear allows treatment in a non-invasive manner while patients remain fully awake.
What are the benefits of using ultrasound for kidney stone treatment?
Ultrasound treatment is shown to significantly reduce the risk of stone recurrence and requires no anesthesia, thereby improving patient convenience and comfort.
Is SonoMotion working on any other kidney stone treatments?
Yes, SonoMotion is also developing the Break Wave™, designed to non-invasively fragment kidney stones without anesthesia in clinical settings.
Where can I find more information about SonoMotion?
To learn more, you can visit SonoMotion's official website for detailed insights into their technologies and advancements in kidney stone treatment.
